BUZZ - JPMorgan downgraded Norwegian Cruise Line's rating to "Underweight," causing its stock price to decline.
路透社2026/10/23 09:52October 23 - ** Shares of cruise operator Norwegian Cruise Line (NCLH.N) fell about 3% in pre-market trading to $15.05
** JPMorgan Securities downgraded the stock from "Neutral" to "Underweight" and cut the target price by $2 to $11
** Annual yield at constant currency is expected to be flat, while the market consensus is for modest growth; ongoing geopolitical headwinds will continue to limit the recovery in demand in the European market, posing downside risks
** The company is expected to reaffirm its full-year outlook when it reports third-quarter results on Thursday
** The fourth quarter is expected to benefit from recent revenue generated by the "Big Wave Waterpark" digital marketing campaign, which may translate into stronger near-term demand for Caribbean itineraries
** Of the 28 brokerages covering the stock, 9 rate it as "Buy" or higher, 17 rate it as "Hold," and 2 rate it as "Sell;" the median target price is $18.50 — data compiled by LSEG
** As of the close of the previous trading day, the stock had fallen about 31% this year
(To assist non-English speakers, Reuters has automated the translation of its reporting into several additional languages. As automated translations may contain errors or lack the required context, Reuters does not guarantee the accuracy of the translated text. The automated translation is provided solely for the reader's convenience. Reuters accepts no responsibility for any damages or losses arising from the use of the automated translation feature.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.
After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.
Hong Kong live music service provider Guitar Group applies for US IPO, aiming to raise $31 million
Guitar Group, a provider of music performance events, guitar-making workshops, and guitar repair services, submitted an application to the U.S. Securities and Exchange Commission (SEC) on Thursday, seeking to raise up to $31 million through an initial public offering (IPO).
Crypto prices
More
